Christopher Benecchi - Chief Operating Officer at Sage Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Operating Officer
Stock Symbol
SAGE on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Christopher Benecchi since 4/23/2024

Holdings reported by Christopher Benecchi for Sage Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 48.4K $335K $6.91 Apr 10, 2025 Direct
Stock Options (Right to buy) 40K Jan 16, 2025 Direct Common Stock
Stock Option (Right to buy) 12.5K Nov 1, 2024 Direct Common Stock

Transactions reported by Christopher Benecchi for Sage Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.